The global Cardiac ablation market was valued at US$ 3.29 billion in 2021 and it is anticipated to grow up to US$ 11.34 billion by 2031, at a CAGR of 13% during the forecast period.
Cardiac ablation, also known as radiofrequency ablation or pulmonary vein ablation, is a treatment for atrial fibrillation. It works by causing small scars in heart tissue with energy or by damaging heart tissue and causing an irregular heartbeat. There are two kinds of ablation: radiofrequency ablation and cryoablation. It works by inserting a long, flexible tube into a vein or artery in the groyne and threading it to the heart to deliver energy in the form of heat. There are numerous factors that can cause cardiac arrhythmia. Pre-existing medical conditions such as diabetes, hypertension, hyperthyroidism, mental stress, heart conditions, old age, and other such factors, as well as lifestyle-related factors such as smoking, alcohol abuse, drug abuse, excessive caffeine consumption, and others, are examples of such factors. Furthermore, certain dietary supplements, herbal treatments, and medications can cause cardiac arrhythmia.
To Remain ‘Ahead’ Of Your Competitors, Request for A Sample – https://www.globalinsightservices.com/request-sample/GIS24308
The key players studied in the global Cardiac Ablation Market are Abbott Laboratories (US), AngioDynamics, Inc. (US), AtriCure Inc., Biotronik SE & Co. KG. (Germany), Boston Scientific Corporation (US), Conmed Corporation (US), Japan Lifeline (Japan), Medtronic plc (Ireland), MicroPort Scientific Corporation (China), Stereotaxis, Inc. (US)
By Product
By End-User
Get Customized Report as Per Your Requirement – https://www.globalinsightservices.com/request-customization/GIS24308
The increase in cases of atrial fibrillation among people all over the world is the primary driver of the industry’s growth. The global elderly population is growing, which is fueling the growth of the cardiac ablation market. According to the National Library of Medicine, people over the age of 80 are more likely to develop atrial fibrillation, one of the most common types of arrhythmias. Furthermore, according to the Centers for Disease Control and Prevention, nearly 12.1 million people in the United States will have AFib by 2030. As a result, the growing geriatric population base, combined with an increasing number of atrial fibrillation cases, will create lucrative market development opportunities.
Furthermore, the industry’s growth will be driven by rising risk factors and advances in the treatment of cardiac rhythm disorders. Growing awareness of better healthcare services, as well as an increase in the number of ablation centers, will boost the overall growth of the cardiac ablation industry. The use of cardiac ablation will increase as healthcare infrastructure improves. These factors are expected to drive the growth of the global Cardiac Ablation Market.
For In-Depth Competitive Analysis, Purchase this Report – https://www.globalinsightservices.com/inquiry-before-buying/GIS24308
With Global Insight Services, you receive:
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
This Press Release has been written with the intention of providing accurate market information which will enable our readers to make informed strategic investment decisions. If you notice any problem with this content, please feel free to reach us on mediarelations@xherald.com.